Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1862150 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $4.76Day +5.19%Mkt cap $63M1Y −8.3%Off 52W high −60.0%Vol (1Y) 93.8%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,160 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest12.6% of sh out |
| Days to cover4.8d |
| 13F net flow (QoQ)+0.82% |
| Top-10 13F concentration80.5% |
| Next report (est.)2026-08-13 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$27.9M |
| ROE−450.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+9.7% |
| 1Y−8.3% |
| 3Y−96.2% |
| Since incept. (ann.)−68.0% |
Total return through 2026-07-30 · series begins 2021-12-09. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)93.8% |
| Ann. volatility (3Y)240.0% |
| Sharpe (1Y)0.39 |
| Sharpe (3Y)0.26 |
| Max drawdown (1Y)−69.1% |
| Max drawdown (3Y)−99.0% |
| Beta (3Y vs SPY)−1.48 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 308,967 | $2M | 2.66% | new |
| Kestra Advisory Services, LLC | 140,000 | $869,400 | 1.20% | +14.8% |
| GEODE CAPITAL MANAGEMENT, LLC | 101,373 | $629,751 | 0.87% | +66.1% |
| MARSHALL WACE, LLP | 92,934 | $577,120 | 0.80% | new |
| JANE STREET GROUP, LLC | 90,867 | $564,284 | 0.78% | new |
| XTX Topco Ltd | 53,503 | $332,254 | 0.46% | +157.9% |
| BCV Asset Management Inc. | 51,200 | $317,938 | 0.44% | new |
| VANGUARD FIDUCIARY TRUST CO | 50,074 | $310,960 | 0.43% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$0.95 | — | — | — |
| 2025-09-30 | 2025-11-13 | −$1.35 | — | — | — |
| 2025-06-30 | 2025-08-19 | −$1.09 | — | — | — |
| 2025-03-31 | 2025-05-08 | −$1.06 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-13 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
